Skip to main content

June 10, 2024

Erica Sparkenbaugh, PhD has paper published in Research and Practices in Thrombosis and Haemostasis

A manuscript entitled “Disease severity drives thrombosis risk in women with sickle cell disease in a single-center retrospective study” was recently accepted in Research and Practice in Thrombosis and Haemostasias. The research was initiated by Jennifer Light, MD, during her fellowship in the Pediatrics Division of Hematology and Oncology. She performed her basic research …

June 7, 2024

Alisa Wolberg and Karin Leiderman awarded MPI NIH R01 Grant

A new MPI NIH R01 was awarded to Alisa Wolberg, PhD and Karin Leiderman, PhD of University of North Carolina at Chapel Hill School of Medicine, entitled: “Interdisciplinary Approach to Elucidate Modifiers of Bleeding Phenotype in Factor XI Deficiency.” PROJECT SUMMARY Congenital deficiency of plasma clotting factor (F)XI is an autosomal disorder. Whereas some individuals are asymptomatic (non-bleeders), others have …

June 7, 2024

Karin Leiderman, PhD gets paper published in The Journal of Mathematical Biosciences

Jamie Madrigal, Mac Monroe, Suzanne Sindi, Karin Leiderman, from The University of North Carolina at Chapel Hill School of Medicine, had a new paper published in Mathematical Biosciences. “Modeling the Distribution of Enzymes on Lipid Vesicles: A Novel Framework for Surface-Mediated Reactions in Coagulation”. Abstract Blood coagulation is a network of biochemical reactions wherein dozens …

December 10, 2019

Kasztan

I have been committed to building a strong translational research program to address novel challenges and questions related to blood and renal pathophysiology in rodents and humans. My work provided strong pre-clinical evidence that endothelin system significantly contributes to sickle cell renal pathophysiology. My collaborative efforts with Dr. Lebensburger identified predictors of the onset of long-term kidney insufficiency and uncovered clear sex differences in the rate of sickle cell nephropathy progression in patients and murine model of sickle cell disease. My current research focuses on functional significance of iron homeostasis in chronic kidney disease (CKD), in particular, the mechanisms of renal iron handling in progressive sickle cell nephropathy. Currently, my lab has three on-going research projects: 1) elucidating molecular mechanisms of endothelin system-mediated renal iron handling in murine models of iron overload; 2) mechanisms of renal dysfunction in sickle cell trait, 3) identifying risk factors for early progression to CKD in sickle cell pediatric patients.